カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界のドラッグクローズドシステムトランスミッション市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Drug Closed System Transmission Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO17587）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO17587
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医療機器
■ ページ数：95
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界のドラッグクローズドシステムトランスミッション市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

ドラッグクローズドシステムトランスミッション市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界のドラッグクローズドシステムトランスミッションの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ドラッグクローズドシステムトランスミッション市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・クローズドバイアルアクセスデバイス、クローズドシリンジセーフティデバイス、クローズドバッグ/ラインアクセスデバイス

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界のドラッグクローズドシステムトランスミッション市場の主要な市場プレーヤーは以下のとおりです。
・Equashield、BD Medical、Teva Medical、ICU Medical、Corvida Medical、B. Braun

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、ドラッグクローズドシステムトランスミッション製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なドラッグクローズドシステムトランスミッションメーカーの企業概要、2019年～2022年までのドラッグクローズドシステムトランスミッションの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なドラッグクローズドシステムトランスミッションメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ドラッグクローズドシステムトランスミッションの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのドラッグクローズドシステムトランスミッションの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのドラッグクローズドシステムトランスミッション市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびドラッグクローズドシステムトランスミッションの産業チェーンを掲載しています。
・第13、14、15章では、ドラッグクローズドシステムトランスミッションの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- ドラッグクローズドシステムトランスミッションの概要
- 種類別分析（2017年vs2021年vs2028年）：クローズドバイアルアクセスデバイス、クローズドシリンジセーフティデバイス、クローズドバッグ/ラインアクセスデバイス
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界のドラッグクローズドシステムトランスミッション市場規模・予測
- 世界のドラッグクローズドシステムトランスミッション生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Equashield、BD Medical、Teva Medical、ICU Medical、Corvida Medical、B. Braun
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：クローズドバイアルアクセスデバイス、クローズドシリンジセーフティデバイス、クローズドバッグ/ラインアクセスデバイス
・用途別分析2017年-2028年：病院、診療所、その他
・ドラッグクローズドシステムトランスミッションの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ドラッグクローズドシステムトランスミッションのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ドラッグクローズドシステムトランスミッションのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ドラッグクローズドシステムトランスミッションの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・ドラッグクローズドシステムトランスミッションの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Drug Closed System Transmission market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Drug Closed System Transmission market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital accounting for % of the Drug Closed System Transmission global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Closed Vial Access Device segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Drug Closed System Transmission include Equashield, BD Medical, Teva Medical, ICU Medical, and Corvida Medical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Drug Closed System Transmission market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Closed Vial Access Device
Closed Syringe Safety Device
Closed Bag/Line Access Device
Market segment by Application can be divided into
Hospital
Clinic
Other
The key market players for global Drug Closed System Transmission market are listed below:
Equashield
BD Medical
Teva Medical
ICU Medical
Corvida Medical
B. Braun
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Drug Closed System Transmission product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Drug Closed System Transmission, with price, sales, revenue and global market share of Drug Closed System Transmission from 2019 to 2022.
Chapter 3, the Drug Closed System Transmission competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Drug Closed System Transmission breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Drug Closed System Transmission market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Drug Closed System Transmission.
Chapter 13, 14, and 15, to describe Drug Closed System Transmission sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Drug Closed System Transmission Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Drug Closed System Transmission Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Closed Vial Access Device
1.2.3 Closed Syringe Safety Device
1.2.4 Closed Bag/Line Access Device
1.3 Market Analysis by Application
1.3.1 Overview: Global Drug Closed System Transmission Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Drug Closed System Transmission Market Size & Forecast
1.4.1 Global Drug Closed System Transmission Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Drug Closed System Transmission Sales in Volume (2017-2028)
1.4.3 Global Drug Closed System Transmission Price (2017-2028)
1.5 Global Drug Closed System Transmission Production Capacity Analysis
1.5.1 Global Drug Closed System Transmission Total Production Capacity (2017-2028)
1.5.2 Global Drug Closed System Transmission Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Drug Closed System Transmission Market Drivers
1.6.2 Drug Closed System Transmission Market Restraints
1.6.3 Drug Closed System Transmission Trends Analysis
2 Manufacturers Profiles
2.1 Equashield
2.1.1 Equashield Details
2.1.2 Equashield Major Business
2.1.3 Equashield Drug Closed System Transmission Product and Services
2.1.4 Equashield Drug Closed System Transmission Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 BD Medical
2.2.1 BD Medical Details
2.2.2 BD Medical Major Business
2.2.3 BD Medical Drug Closed System Transmission Product and Services
2.2.4 BD Medical Drug Closed System Transmission Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Teva Medical
2.3.1 Teva Medical Details
2.3.2 Teva Medical Major Business
2.3.3 Teva Medical Drug Closed System Transmission Product and Services
2.3.4 Teva Medical Drug Closed System Transmission Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 ICU Medical
2.4.1 ICU Medical Details
2.4.2 ICU Medical Major Business
2.4.3 ICU Medical Drug Closed System Transmission Product and Services
2.4.4 ICU Medical Drug Closed System Transmission Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Corvida Medical
2.5.1 Corvida Medical Details
2.5.2 Corvida Medical Major Business
2.5.3 Corvida Medical Drug Closed System Transmission Product and Services
2.5.4 Corvida Medical Drug Closed System Transmission Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 B. Braun
2.6.1 B. Braun Details
2.6.2 B. Braun Major Business
2.6.3 B. Braun Drug Closed System Transmission Product and Services
2.6.4 B. Braun Drug Closed System Transmission Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Drug Closed System Transmission Breakdown Data by Manufacturer
3.1 Global Drug Closed System Transmission Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Drug Closed System Transmission Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Drug Closed System Transmission
3.4 Market Concentration Rate
3.4.1 Top 3 Drug Closed System Transmission Manufacturer Market Share in 2021
3.4.2 Top 6 Drug Closed System Transmission Manufacturer Market Share in 2021
3.5 Global Drug Closed System Transmission Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Drug Closed System Transmission Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Drug Closed System Transmission Market Size by Region
4.1.1 Global Drug Closed System Transmission Sales in Volume by Region (2017-2028)
4.1.2 Global Drug Closed System Transmission Revenue by Region (2017-2028)
4.2 North America Drug Closed System Transmission Revenue (2017-2028)
4.3 Europe Drug Closed System Transmission Revenue (2017-2028)
4.4 Asia-Pacific Drug Closed System Transmission Revenue (2017-2028)
4.5 South America Drug Closed System Transmission Revenue (2017-2028)
4.6 Middle East and Africa Drug Closed System Transmission Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Drug Closed System Transmission Sales in Volume by Type (2017-2028)
5.2 Global Drug Closed System Transmission Revenue by Type (2017-2028)
5.3 Global Drug Closed System Transmission Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Drug Closed System Transmission Sales in Volume by Application (2017-2028)
6.2 Global Drug Closed System Transmission Revenue by Application (2017-2028)
6.3 Global Drug Closed System Transmission Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Drug Closed System Transmission Sales by Type (2017-2028)
7.2 North America Drug Closed System Transmission Sales by Application (2017-2028)
7.3 North America Drug Closed System Transmission Market Size by Country
7.3.1 North America Drug Closed System Transmission Sales in Volume by Country (2017-2028)
7.3.2 North America Drug Closed System Transmission Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Drug Closed System Transmission Sales by Type (2017-2028)
8.2 Europe Drug Closed System Transmission Sales by Application (2017-2028)
8.3 Europe Drug Closed System Transmission Market Size by Country
8.3.1 Europe Drug Closed System Transmission Sales in Volume by Country (2017-2028)
8.3.2 Europe Drug Closed System Transmission Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Drug Closed System Transmission Sales by Type (2017-2028)
9.2 Asia-Pacific Drug Closed System Transmission Sales by Application (2017-2028)
9.3 Asia-Pacific Drug Closed System Transmission Market Size by Region
9.3.1 Asia-Pacific Drug Closed System Transmission Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Drug Closed System Transmission Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Drug Closed System Transmission Sales by Type (2017-2028)
10.2 South America Drug Closed System Transmission Sales by Application (2017-2028)
10.3 South America Drug Closed System Transmission Market Size by Country
10.3.1 South America Drug Closed System Transmission Sales in Volume by Country (2017-2028)
10.3.2 South America Drug Closed System Transmission Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Drug Closed System Transmission Sales by Type (2017-2028)
11.2 Middle East & Africa Drug Closed System Transmission Sales by Application (2017-2028)
11.3 Middle East & Africa Drug Closed System Transmission Market Size by Country
11.3.1 Middle East & Africa Drug Closed System Transmission Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Drug Closed System Transmission Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Drug Closed System Transmission and Key Manufacturers
12.2 Manufacturing Costs Percentage of Drug Closed System Transmission
12.3 Drug Closed System Transmission Production Process
12.4 Drug Closed System Transmission Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Drug Closed System Transmission Typical Distributors
13.3 Drug Closed System Transmission Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Drug Closed System Transmission Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Drug Closed System Transmission Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Equashield Basic Information, Manufacturing Base and Competitors
Table 4. Equashield Major Business
Table 5. Equashield Drug Closed System Transmission Product and Services
Table 6. Equashield Drug Closed System Transmission Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. BD Medical Basic Information, Manufacturing Base and Competitors
Table 8. BD Medical Major Business
Table 9. BD Medical Drug Closed System Transmission Product and Services
Table 10. BD Medical Drug Closed System Transmission Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Teva Medical Basic Information, Manufacturing Base and Competitors
Table 12. Teva Medical Major Business
Table 13. Teva Medical Drug Closed System Transmission Product and Services
Table 14. Teva Medical Drug Closed System Transmission Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. ICU Medical Basic Information, Manufacturing Base and Competitors
Table 16. ICU Medical Major Business
Table 17. ICU Medical Drug Closed System Transmission Product and Services
Table 18. ICU Medical Drug Closed System Transmission Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Corvida Medical Basic Information, Manufacturing Base and Competitors
Table 20. Corvida Medical Major Business
Table 21. Corvida Medical Drug Closed System Transmission Product and Services
Table 22. Corvida Medical Drug Closed System Transmission Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. B. Braun Basic Information, Manufacturing Base and Competitors
Table 24. B. Braun Major Business
Table 25. B. Braun Drug Closed System Transmission Product and Services
Table 26. B. Braun Drug Closed System Transmission Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Global Drug Closed System Transmission Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 28. Global Drug Closed System Transmission Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 29. Market Position of Manufacturers in Drug Closed System Transmission, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 30. Global Drug Closed System Transmission Production Capacity by Company, (K Units): 2020 VS 2021
Table 31. Head Office and Drug Closed System Transmission Production Site of Key Manufacturer
Table 32. Drug Closed System Transmission New Entrant and Capacity Expansion Plans
Table 33. Drug Closed System Transmission Mergers & Acquisitions in the Past Five Years
Table 34. Global Drug Closed System Transmission Sales by Region (2017-2022) & (K Units)
Table 35. Global Drug Closed System Transmission Sales by Region (2023-2028) & (K Units)
Table 36. Global Drug Closed System Transmission Revenue by Region (2017-2022) & (USD Million)
Table 37. Global Drug Closed System Transmission Revenue by Region (2023-2028) & (USD Million)
Table 38. Global Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
Table 39. Global Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
Table 40. Global Drug Closed System Transmission Revenue by Type (2017-2022) & (USD Million)
Table 41. Global Drug Closed System Transmission Revenue by Type (2023-2028) & (USD Million)
Table 42. Global Drug Closed System Transmission Price by Type (2017-2022) & (US$/Unit)
Table 43. Global Drug Closed System Transmission Price by Type (2023-2028) & (US$/Unit)
Table 44. Global Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
Table 45. Global Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
Table 46. Global Drug Closed System Transmission Revenue by Application (2017-2022) & (USD Million)
Table 47. Global Drug Closed System Transmission Revenue by Application (2023-2028) & (USD Million)
Table 48. Global Drug Closed System Transmission Price by Application (2017-2022) & (US$/Unit)
Table 49. Global Drug Closed System Transmission Price by Application (2023-2028) & (US$/Unit)
Table 50. North America Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
Table 51. North America Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
Table 52. North America Drug Closed System Transmission Revenue by Country (2017-2022) & (USD Million)
Table 53. North America Drug Closed System Transmission Revenue by Country (2023-2028) & (USD Million)
Table 54. North America Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
Table 55. North America Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
Table 56. North America Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
Table 57. North America Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
Table 58. Europe Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
Table 59. Europe Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
Table 60. Europe Drug Closed System Transmission Revenue by Country (2017-2022) & (USD Million)
Table 61. Europe Drug Closed System Transmission Revenue by Country (2023-2028) & (USD Million)
Table 62. Europe Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
Table 63. Europe Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
Table 64. Europe Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
Table 65. Europe Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
Table 66. Asia-Pacific Drug Closed System Transmission Sales by Region (2017-2022) & (K Units)
Table 67. Asia-Pacific Drug Closed System Transmission Sales by Region (2023-2028) & (K Units)
Table 68. Asia-Pacific Drug Closed System Transmission Revenue by Region (2017-2022) & (USD Million)
Table 69. Asia-Pacific Drug Closed System Transmission Revenue by Region (2023-2028) & (USD Million)
Table 70. Asia-Pacific Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
Table 71. Asia-Pacific Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
Table 72. Asia-Pacific Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
Table 73. Asia-Pacific Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
Table 74. South America Drug Closed System Transmission Sales by Country (2017-2022) & (K Units)
Table 75. South America Drug Closed System Transmission Sales by Country (2023-2028) & (K Units)
Table 76. South America Drug Closed System Transmission Revenue by Country (2017-2022) & (USD Million)
Table 77. South America Drug Closed System Transmission Revenue by Country (2023-2028) & (USD Million)
Table 78. South America Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
Table 79. South America Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
Table 80. South America Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
Table 81. South America Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
Table 82. Middle East & Africa Drug Closed System Transmission Sales by Region (2017-2022) & (K Units)
Table 83. Middle East & Africa Drug Closed System Transmission Sales by Region (2023-2028) & (K Units)
Table 84. Middle East & Africa Drug Closed System Transmission Revenue by Region (2017-2022) & (USD Million)
Table 85. Middle East & Africa Drug Closed System Transmission Revenue by Region (2023-2028) & (USD Million)
Table 86. Middle East & Africa Drug Closed System Transmission Sales by Type (2017-2022) & (K Units)
Table 87. Middle East & Africa Drug Closed System Transmission Sales by Type (2023-2028) & (K Units)
Table 88. Middle East & Africa Drug Closed System Transmission Sales by Application (2017-2022) & (K Units)
Table 89. Middle East & Africa Drug Closed System Transmission Sales by Application (2023-2028) & (K Units)
Table 90. Drug Closed System Transmission Raw Material
Table 91. Key Manufacturers of Drug Closed System Transmission Raw Materials
Table 92. Direct Channel Pros & Cons
Table 93. Indirect Channel Pros & Cons
Table 94. Drug Closed System Transmission Typical Distributors
Table 95. Drug Closed System Transmission Typical Customers
List of Figures
Figure 1. Drug Closed System Transmission Picture
Figure 2. Global Drug Closed System Transmission Revenue Market Share by Type in 2021
Figure 3. Closed Vial Access Device
Figure 4. Closed Syringe Safety Device
Figure 5. Closed Bag/Line Access Device
Figure 6. Global Drug Closed System Transmission Revenue Market Share by Application in 2021
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global Drug Closed System Transmission Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 11. Global Drug Closed System Transmission Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Drug Closed System Transmission Sales (2017-2028) & (K Units)
Figure 13. Global Drug Closed System Transmission Price (2017-2028) & (US$/Unit)
Figure 14. Global Drug Closed System Transmission Production Capacity (2017-2028) & (K Units)
Figure 15. Global Drug Closed System Transmission Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Drug Closed System Transmission Market Drivers
Figure 17. Drug Closed System Transmission Market Restraints
Figure 18. Drug Closed System Transmission Market Trends
Figure 19. Global Drug Closed System Transmission Sales Market Share by Manufacturer in 2021
Figure 20. Global Drug Closed System Transmission Revenue Market Share by Manufacturer in 2021
Figure 21. Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Drug Closed System Transmission Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Drug Closed System Transmission Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Drug Closed System Transmission Sales Market Share by Region (2017-2028)
Figure 25. Global Drug Closed System Transmission Revenue Market Share by Region (2017-2028)
Figure 26. North America Drug Closed System Transmission Revenue (2017-2028) & (USD Million)
Figure 27. Europe Drug Closed System Transmission Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Drug Closed System Transmission Revenue (2017-2028) & (USD Million)
Figure 29. South America Drug Closed System Transmission Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Drug Closed System Transmission Revenue (2017-2028) & (USD Million)
Figure 31. Global Drug Closed System Transmission Sales Market Share by Type (2017-2028)
Figure 32. Global Drug Closed System Transmission Revenue Market Share by Type (2017-2028)
Figure 33. Global Drug Closed System Transmission Price by Type (2017-2028) & (US$/Unit)
Figure 34. Global Drug Closed System Transmission Sales Market Share by Application (2017-2028)
Figure 35. Global Drug Closed System Transmission Revenue Market Share by Application (2017-2028)
Figure 36. Global Drug Closed System Transmission Price by Application (2017-2028) & (US$/Unit)
Figure 37. North America Drug Closed System Transmission Sales Market Share by Type (2017-2028)
Figure 38. North America Drug Closed System Transmission Sales Market Share by Application (2017-2028)
Figure 39. North America Drug Closed System Transmission Sales Market Share by Country (2017-2028)
Figure 40. North America Drug Closed System Transmission Revenue Market Share by Country (2017-2028)
Figure 41. United States Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Drug Closed System Transmission Sales Market Share by Type (2017-2028)
Figure 45. Europe Drug Closed System Transmission Sales Market Share by Application (2017-2028)
Figure 46. Europe Drug Closed System Transmission Sales Market Share by Country (2017-2028)
Figure 47. Europe Drug Closed System Transmission Revenue Market Share by Country (2017-2028)
Figure 48. Germany Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Drug Closed System Transmission Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Drug Closed System Transmission Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Drug Closed System Transmission Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Drug Closed System Transmission Revenue Market Share by Region (2017-2028)
Figure 57. China Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Drug Closed System Transmission Sales Market Share by Type (2017-2028)
Figure 64. South America Drug Closed System Transmission Sales Market Share by Application (2017-2028)
Figure 65. South America Drug Closed System Transmission Sales Market Share by Country (2017-2028)
Figure 66. South America Drug Closed System Transmission Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Drug Closed System Transmission Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Drug Closed System Transmission Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Drug Closed System Transmission Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Drug Closed System Transmission Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Drug Closed System Transmission Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Drug Closed System Transmission in 2021
Figure 78. Manufacturing Process Analysis of Drug Closed System Transmission
Figure 79. Drug Closed System Transmission Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の閉鎖気管吸引システム市場2022年：市場規模予測（～2028年）
  • 世界の間欠カテーテル閉鎖式システム市場2022年：市場規模予測（～2028年）
  • 医療用閉鎖型人工呼吸器呼吸回路のグローバル市場展望 2023年-2029年：全閉、半閉
  • クローズドシステム転送デバイス（CSTD）のグローバル市場展望 2023年-2029年：クローズドシステム開発用、空気清浄装置用
  • 間欠式カテーテル閉鎖装置のグローバル市場展望 2023年-2029年：ストレートチップカテーテル、クーデチップカテーテル
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO17587 )"世界のドラッグクローズドシステムトランスミッション市場2022年：市場規模予測（～2028年）" (英文：Global Drug Closed System Transmission Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。